Rockwell Medical, Inc. (RMTI) Stake Maintained by Alliancebernstein L.P.
Alliancebernstein L.P. held its position in Rockwell Medical, Inc. (NASDAQ:RMTI) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 71,000 shares of the company’s stock at the close of the second quarter. Alliancebernstein L.P. owned approximately 0.14% of Rockwell Medical worth $563,000 at the end of the most recent quarter.
Other institutional investors have also bought and sold shares of the company. KCG Holdings Inc. bought a new position in shares of Rockwell Medical in the 1st quarter worth about $111,000. Private Advisor Group LLC bought a new position in shares of Rockwell Medical in the 2nd quarter worth about $182,000. American International Group Inc. lifted its position in shares of Rockwell Medical by 7.1% in the 1st quarter. American International Group Inc. now owns 29,509 shares of the company’s stock worth $185,000 after buying an additional 1,955 shares during the last quarter. Cutter & CO Brokerage Inc. lifted its position in shares of Rockwell Medical by 6.3% in the 2nd quarter. Cutter & CO Brokerage Inc. now owns 25,325 shares of the company’s stock worth $201,000 after buying an additional 1,500 shares during the last quarter. Finally, Metropolitan Life Insurance Co. NY lifted its position in shares of Rockwell Medical by 11.3% in the 1st quarter. Metropolitan Life Insurance Co. NY now owns 42,220 shares of the company’s stock worth $264,000 after buying an additional 4,287 shares during the last quarter. Institutional investors own 21.35% of the company’s stock.
A number of research analysts have recently issued reports on the stock. Zacks Investment Research downgraded shares of Rockwell Medical from a “hold” rating to a “sell” rating in a research report on Tuesday, August 15th. BidaskClub upgraded shares of Rockwell Medical from a “sell” rating to a “hold” rating in a research report on Wednesday, August 23rd. Finally, Ifs Securities assumed coverage on shares of Rockwell Medical in a research report on Monday, August 14th. They issued a “strong-buy” rating and a $11.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. Rockwell Medical has an average rating of “Hold” and a consensus target price of $8.88.
Shares of Rockwell Medical, Inc. (NASDAQ:RMTI) opened at $6.05 on Friday.
Rockwell Medical (NASDAQ:RMTI) last released its quarterly earnings data on Wednesday, August 9th. The company reported ($0.14) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.10) by ($0.04). Rockwell Medical had a negative return on equity of 42.22% and a negative net margin of 39.68%. The firm had revenue of $13.24 million during the quarter, compared to analyst estimates of $13.05 million. During the same period last year, the business earned ($0.11) EPS. The firm’s revenue was down 1.6% on a year-over-year basis. analysts predict that Rockwell Medical, Inc. will post -0.39 EPS for the current year.
COPYRIGHT VIOLATION WARNING: “Rockwell Medical, Inc. (RMTI) Stake Maintained by Alliancebernstein L.P.” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another site, it was illegally copied and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/11/04/rockwell-medical-inc-rmti-stake-maintained-by-alliancebernstein-l-p.html.
About Rockwell Medical
Rockwell Medical, Inc (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process.
Want to see what other hedge funds are holding RMTI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rockwell Medical, Inc. (NASDAQ:RMTI).
Receive News & Stock Ratings for Rockwell Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical Inc. and related stocks with our FREE daily email newsletter.